Prevention and management of stroke

Wolf PA , Kannel WB , Verter J. Current status of risk factors for stroke. Neurol Clin 1983; 1: 312-44.

Tell GS , Crouse JR , Furberg CD Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis . Stroke 1988; 19: 423-30.

Wu KK , Hoak JC Increased platelet aggregates in patients with transient ischemic attacks . Stroke 1975; 6: 521-24.

Ott EO , Ladurner G. , Lechner H. Relationship between disturbed rheological properties and cerebral hemodynamics in recent cerebral infarction. Prog Biochem 1977; 14: 349-52.

Grotta JC , Ackerman R. , Correia J. , Fallick G. , Chang J. Whole blood viscosity parameters and cerebral blood flow. Stroke 1982; 13: 296-301.

Crouse JR , Toole JF , McKinney WM et al. Risk factors for extracranial carotid artery atherosclerosis . Stroke 1987; 19: 990-96.

Grotta JC , Yatsu FM , Pettigrew LC et al. Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology 1989; 39: 1325-31.

Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488-99.

Steinberg D. Lipoproteins and the pathogenesis of atherosclerosis . Circulation 1987; 76: 508-14.

National Cholesterol Education Program Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.

Leaf A. , Weber PC Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318: 549-57.

Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988; 296: 320-31.

Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989; 321: 129-35.

Uk-Tia Study Group. United Kingdom transient ischemic attack (UK-TIA) aspirin trial: interim results. Br Med J 1988; 296: 316-19.

Boysen G. , Sorensen P. , Juhler M. et al. Danish very-low-dose aspirin after carotid endarterectomy trial . Stroke 1988; 19: 1211-15.

Petersen P. , Boysen G. , Godtfredsen J. , Andersen ED , Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic artrial fibrillation. Lancet 1989; i: 175-79.

ESPS Group. European stroke prevention study. Stroke 1990; 21: 1122-30.

Grotta JC , Lemak NA , Gary H. et al. Does platelet antiaggregant therapy lessen the severity of stroke ? Neurology 1985; 35: 632-36.

Hass WK , Easton JD , Adams HP et al. A randomized trial comparing the efficacy of ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989; 321: 501-507.

Gent M. , Blakeley JA , Easton D. et al. The Canadian American ticlopidine study (CATS) in thromboembolic stroke. Lancet 1989; i: 1215-20.

Dyken MI Anticoagulant and platelet antiaggregating therapy in stroke and threatened stroke. Neurol Clin 1983; 1: 223-42.

Kase CS , Robinson RK , Stein RW et al. Anticoagulant-related intracerebral hemorrhage. Neurology 1985; 35: 943-48.

Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 322: 863-68.

Biller J. , Bruno A. , Adams HP et al. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks - a pilot study. Stroke 1989; 20: 441-47.

Grotta JC Current medical and surgical therapy for cerebrovascular disease. N Engl J Med 1987; 317: 1505-16.

Hobson RW , Towne J. Carotid endarterectomy for asymptomatic carotid stenosis. Stroke 1989; 20: 575-76.

The Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke 1989; 20: 844-49.

Theron J. , Raymond J. , Casasco A. , Courtheoux F. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. AJNR 1987; 8: 495-500.

Higashida RT , Hieshima GB , Tsai FY , Halbach VV , Norman D. , Newton TH Transluminal angioplasty of the vertebral and basilar artery. AJNR 1987; 8: 745-49.

Kushner M. , Nencini P. , Reivich M. et al. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol 1990; 28: 129-35.

Minamisawa H. , Smith ML , Siesjo BK The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol 1990; 28: 26-33.

Duke RJ , Bloch RF , Turpie Agg , Trebilcock R. , Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial. Ann Intern Med 1986; 105: 825-28.

Whisnant JP Discussion of progressing stroke: anticoagulant therapy. In: Milikan CH , Siekert RH , Whisnant JP eds. Cerebral vascular diseases: Third Princeton Conference. New York: Grune & Stratton, 1961: 182-83.

Ramirez-Lassepas M. , Cipolle RJ , Rodvold KA et al. Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease. Neurology 1984; 34: 736-40.

Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1989; 46: 727-43.

Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 1983; 14: 668-76.

Shields RW Jr, Laureno R. , Lachman T. , Victor M. Anticoagulant-related hemorrhage in acute cerebral embolism. Stroke 1984; 15: 426-37.

Lodder J. , van der Lugt Pjm. Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. Stroke 1983 ; 14: 42-46.

Rothrock JF , Dittrich HC , McAllen S. , Taft BJ , Lyden PD Acute anticoagulation following cardioembolic stroke. Stroke 1989; 20: 730-34.

Yatsu FM , Hart RG , Mohr JP , Grotta JC Anticoagulation of embolic strokes of cardiac origin: an update. Neurology 1988; 38: 314-16.

Massey EW , Biller J. , Davis JN et al. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke . Stroke 1990; 21: 1289-92.

Hsu CY , Faught RE Jr, Furlan AJ et al. Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial. Stroke 1987; 18: 352-58.

Gelmers HJ , Gorter K. , de Weerdt CJ , Wiezer Jha. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988; 318: 203-207.

Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke: results in the total patient population. Stroke 1987; 18: 691-99.

Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke: results of subgroup analyses. Stroke 1988; 19: 464-71.

Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 1988; i: 318-21.

Pentoxifylline Study Group. Pentoxifylline (PTX) in acute ischemic stroke. Stroke 1987; 18: 298.

The Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke: results of a randomized multicenter trial using pentastarch. Stroke 1989; 20: 317-23.

Del Zoppo GJ , Zeumer H. , Harker LA Thrombolytic therapy in stroke: possibilities and hazards. Stroke 1986; 17: 595-607.

Mori E. , Tabuchi M. , Yoshida T. , Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988; 19: 802-12.

Sherry S. Tissue plasminogen activator (t-PA): will it fulfill its promise? N Engl J Med 1984; 313: 1014-17.

Zivin JA , Fisher M. , DeGirolami U. , Hemenway CC , Stashak JA Tissue plasminogen activator reduced neurological damage after cerebral embolism . Science 1985; 230: 1289-92.

Brott T. , Haley C. , Levy D. et al. Safety and potential efficacy of tissue plasminogen activator (tPA) for stroke. Stroke 1990; 21: 181.

Haley EC , Levy D. , Sheppard G. et al. A dose-escalation safety study of intravenous tissue plasminogen activator in patients treated from 90 to 180 minutes from onset of acute ischemic stroke. Ann Neurol 1990; 28: 255.

Raichle ME : The pathophysiology of brain ischemia. Ann Neurol 1983; 13: 2-10.

Wieloch T. , Harris RJ , Siesjo BK Brain metabolism and ischemia: mechanism of cell damage and principals of protection. J Cereb Blood Flow Metab 1982; vmr-2 (suppl 1): S5-9.

Haas WK Beyond cerebral blood flow, metabolism and ischemic thresholds: an examination of the role of calcium in the initiation of cerebral infarction. In: Meyer JS, Lechner H, Reivich M, Ott EO, Arabinar A eds. Cerebral vascular disease 3: proceedings of the 10th International Salzburg Conference. Amsterdam: Excerpta Medica, 1981 : 3-17.

Picone CM , Grotta JC , Earls J. , Strong R. , Dedman J. Immunohistochemical determination of calcium-calmodulin binding predicts neuronal damage after global ischemia. J Cereb Blood Flow Metab 1989; 9: 805-11.

Kazda S. , Hoffmeister F. , Garthoff B. , Towart R. Prevention of the postischaemic impaired reperfusion of the brain by nimodipine (BAY e 9736). Acta Neurol Scand 1979; 72 (Suppl): 302-303.

Steen PA , Newberg IA , Milde JH , Michenfelder JD Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1983; 3: 38-43.

Grotta JC , Pettigrew LC , Rosenbaum D. , Reid C. , Rhoades H. , McCandless D. Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke 1988; 19: 447-54.

Thayer S. , Murphy S. , Miller R. Widespread distribution of dihydropyridine sensitive calcium channels in the central nervous system. Mol Pharmacol 1986 ; 30: 505-509.

Allen GS , Ahn HS , Preziosi TJ et al. Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619-24.

Petrak K. , West M. , Mohr G. et al. Nimodipine treatment in poor grade aneurysm patients. J Neurosurg 1988; 68: 505-17.

Mee E. , Dorrance D. , Lowe D. , Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 1988; 22: 484-91.

Martinez-Vila E. , Guillen F. , Villaneuva JA et al. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke 1990; 21: 1023-28.

Mohr JP , Dilanni M. , Muschett JL et al. Nimodipine in acute ischemic stroke. Ann Neurol 1989; 26: 124.

Rosenbaum DM , Grotta JC , Yatsu FM et al. Pilot study of nicardipine for acute ischemic stroke. Angiology (in press).

Davalos A. , Cendra E. , Gonzalez B. et al. Double-blind randomized clinical trial of nicardipine vs placebo in acute ischemic stroke: clinical, radiological and biochemical evaluation of the ischemic area. Preliminary results. Presented at the 14th World Congress of Neurology, New Delhi, October 27, 1989.

Limburg M. , Hijdra A. Flunarizine in acute ischemic stroke: a pilot study. Presented at the 14th World Congress of Neurology, New Delhi, October 27, 1989.

Choi DW Glutamate neurotoxicity in cortical cell culture is calcium-dependent. Neurosci Lett 1985; 58: 293-97.

Rothman SM , Olney JW Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19: 105-11.

Pulsinelli WA Deafferentation of the hippocampus protects CA1 pyramidal neurons against ischemic injury. Stroke 1985; 16: 144.

von Lubitz Dkje , Dambrosia JM , Kempski O. , Redmond DJ Cyclohexyl adenosine protects against neuronal death following ischemia in CA1 region of gerbil hippocampus. Stroke 1988; 19: 1133-39.

Pettigrew LC , Rosenbaum DM , Ostrow PT , Grotta JC The effect of baclofen on regional glutamate levels in normal and ischemic brain. J Cereb Blood Flow Metab 1989; 9 (suppl 1): S304.

Simon RP , Swan JH , Griffiths T. , Meldrum BS Blockade of NMDA receptors may protect against ischemic damage in the brain . Science 1984; 226: 850-52.

Kochhar A. , Zivin JA , Lyden PD , Mazzarella V. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol 1988; 45: 148-53.

Park CK , Nehls DG , Graham DI , Teasdale GM , McCulloch J. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 1988; 8: 757-62.

Swan JH , Meldrum BS Early, not late, administration of NMDA receptor antagonists protects against selective ischaemic cell loss. J Cereb Blood Flow Metab 1989; 9 (Suppl 1): S558.

Olney JW , Labruyere J. , Price MT Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-62.

Steinberg GK , Saleh J. , Kunis D. et al. Protective effect of n-methyl-d-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke 1989; 20: 1247-52.

Grotta JC , Picone CM , Ostrow PT et al. CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Ann Neurol 1990; 27: 612-19.

Albers GW , Goldberg MP , Choi DW N-methyl-d-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 1989; 25: 398-403.

Cerchiari EL , Hoel TM , Safar P. , Sclabassi RJ Protective effects of combined superoxide dismutase and desferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs. Stroke 1987; 18: 869-78.

Imaizumi S. , Woolworth V. , Fishman RA , Chan PH Superoxide dismutase activities and their role in focal cerebral ischemia. J Cereb Blood Flow Metab 1989; 9 (suppl 1): S217.

Hall E. , Pazara K. , Braugher JM 21-aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 1988; 19: 997-1002.

Komatsumoto S. , Greenberg J. , Hickey W. , Reivich M. Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats. Stroke 1988; 19: 1027-35.

Jamieson DG , Reivich M. , Alves W. et al. Ganglioside (GM1) treatment of acute ischemic infarction: a randomized, double-blind study using positron emission tomography. Neurology 1989; 39 (suppl 1): 217.

Argentino C. , Sacchetti ML , Toni D. et al. GM1 ganglioside therapy in acute ischemic stroke. Stroke 1989; 20: 1143-49.

Faden AI , Jacobs TP , Holaday JW Opiate antagonist improves neurologic recovery after spinal injury. Science 1981; 211: 493-94.

Young W. , Flamm ES , Demopoulos HB et al. Naloxone ameliorates post-traumatic ischemia in experimental spinal contusion. J Neurosurg 1981; 55: 209-19.

Hosobuchi Y. , Baskin WS , Woo SK Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 1982; 215: 69-71.

Olinger CP , Adams HP , Brott TG et al. High-dose intravenous naloxone for the treatment of acute ischemic stroke. Stroke 1990; 21: 721-25.

Tang AH Protection from cerebral ischemia by U-50, 488E, a specific kappa opioid analgesic agent. Life Sci 1985; 37: 1475-82.

De Reuck J. , Vandekerckhove T. , Bosma G. et al. Steroid treatment in acute ischaemic stroke. Eur Neurol 1988; 28: 70-72.

Paal G. , Grossmann W. , Kick J. , Velho-Groneberg P. Dexamethasone and stroke - a one year follow-up study. Presented at the 14th World Congress of Neurology, New Delhi, October 27, 1989.

Bayer AJ , Pathy Msj , Newcome R. Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet 1987: 405-408.

Gelmers HJ Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke. Acta Neurol Scand 1980; 61: 313-18.

Robinson RG , Price TR Post-stroke depressive disorders: a follow-up study of 103 patients. Stroke 1982;13:635-41.

Finklestein S. , Benowitz LI , Baldessarini RJ et al. Mood, vegetative disturbance and dexamethasone suppression test after stroke. Ann Neurol 1982; 12: 463-68.

Lipsey JR , Robinson RG , Pearlson GD , Rao K. , Price TR Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984; i: 297-300.

Reding JR , Orta LA , Winter SW , Fortuna IM , DiPonte P. , McDowell FH Antidepressant therapy after stroke. Arch Neurol 1986; 43: 763-65.

Parikh RM , Robinson RG , Lipsey JR , Price TR Nortriptyline treatment of post-stroke emotional lability: a double-blind study. Neurology 1989; 39 (suppl 1): 177.

Fleet WS , Valenstein E. , Watson RT , Heilman KM Dopamine agonist therapy for neglect in humans. Neurology 1987; 37: 1765-70.

Albert ML , Bachman DL , Morgan A. , Helm-Estabrooks N. Pharmacotherapy for aphasia. Neurology 1988 ; 38: 877-79.

Sivenius J. , Pyorala K. , Heinonen O. et al. The significance of intensity of rehabilitation of stroke - a controlled trial. Stroke 1985 ; 16: 928-31.

Strand T. , Asplund K. , Eriksson S. et al. Stroke unit care - who benefits? Comparisons with general medical care in relation to prognostic indicators on admission. Stroke 1986; 17: 377-81.

Dignan MB , Howard G. , Toole JF et al. Evaluation of the North Carolina Stroke Care Program. Stroke 1986; 17: 817-30.

Lincoln NB , McGuirk E. , Mulley GP et al. Effectiveness of speech therapy for aphasic stroke patients: a randomised controlled trial. Lancet 1984; i: 1197-1200.

Wentz RT , Weiss DG , Aten JL et al. Comparison of clinic, home, and deferred language treatment for aphasia: a Veterans Administration Cooperative Study. Arch Neurol 1986; 43: 653-58.

Wender D. Aphasic victim as investigator. Arch Neurol 1989; 46: 91-92.

Ojemann RG , Heros RC Spontaneous brain hemorrhage. Stroke 1983; 14: 468-75.

Helweg-Larsen S. , Sommer W. , Strange P. , Lester J. , Boysen G. Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke 1984; 15: 1045-48.

Ott KH , Kase CS , Ojemann RG , Mohr JP Cerebellar hemorrhage: diagnosis and treatment: a review of 56 cases. Arch Neurol 1974; 31: 160-67.

Rockoff MA , Ropper AH Treatment of intracranial hypertension. In: Ropper AH , Kennedy FK , Zervas NT eds. Neurological and neurosurgical intensive care. Baltimore: University Park Press, 1983: 21-37.

Tellez H. , Bauer RB Dexamethasone as treatment in cerebrovascular disease: a controlled study in intracerebral hemorrhage. Stroke 1973; 4: 541-46.

Rockoff MA , Marshall LF , Shapiro HM High-dose barbiturate therapy in humans: a clinical review of 60 patients. Ann Neurol 1979; 6: 194-99.

Spetzler RF , Martin NA A proposed grading system for arteriovenous malformations. J Neurosurg 1986; 65: 476-83.

Shi Y-Q. , Chen X-C. A proposed scheme for grading intracranial arteriovenous malformations. J Neurosurg 1986; 65: 484-89.

Luessenhop AJ , Rosa L. Cerebral arteriovenous malformations: indications for and results of surgery, and the role of intravascular techniques. J Neurosurg 1984; 60: 14-22.

Wilkins RH Natural history of intracranial vascular malformations: a review. Neurosurgery 1985; 16: 421-30.

Kjellberg RN , Hanamura T. , Davis KR , Lyons SL , Adams RD Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 1983 ; 309: 269-74.

Steinberg GK , Silverberg GD , Fabrikant JI et al. Preliminary results of heavy particle radiation for arteriovenous malformations of the brain. Stroke 1988; 19: 24.

Steiner L. Radiosurgery in cerebral arteriovenous malformations. In: Flamm E , Fein J eds. Textbook of cerebrovascular surgery. New York : Springer Verlag, 1986:1161-1215.

Kassell NF , Torner JC , Jane JA et al. The international cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg 1990; 73: 37-47.

Kassell NF , Torner JC , Adams HP Jr. Antifibrinolytic therapy in the acute period following aneurysmal arachnoid hemorrhage: preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 1984 ; 61: 225-30.

Vermeulen M. , Lindsay KW , Murray GD et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 1984; 311: 432-37.

Adams H. , Flamm E. , Beck D. , Godersky J. , Pinto R. A study of nicardipine in prevention of infarction after subarachnoid hemorrhage . Stroke 1987; 18: 281.

Kassell NF , Peerless SJ , Durward QJ et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension . Neurosurgery 1982; 11: 337-43.

Awad IA , Carter LP , Spetzler RF et al. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18: 365-72.

Solomon RA , Fink ME , Lennihan L. Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery. Arch Neurol 1988; 45: 325-32.

Hasan D. , Vermeulen M. , Wijdicks E. , Hijdra A. , van Gijn I. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke 1989; 20: 747-53.

Heros RC Acute hydrocephalus after subarachnoid hemorrhage. Stroke 1989; 20: 715-17.